Predictive efficacy of plasma ATF4 and vWF levels in patients with persistent atrial fibrillation after radiofrequency ablation
Time：2022-07-21 Source：
参考文献(References)：
[1] Steffel J,Collins R,Antz M,et al.2021
European Heart Rhythm Association Practical Guide on the use of
non-vitamin K antagonist oral anticoagulants in patients with atrial
fibrillation[J].Europace,2021,23(10):1612-1676.DOI:10.1093/europace/euab065.
[2]
中华医学会，中华医学会临床药学分会，中华医学会杂志社，等.心房颤动基层合理用药指南[J].中华全科医师杂志，2021,20(2):166-174.DOI:10.3760/cma.j.cn114798-20201210-01241.Chinese
Medical Association,Chinese Society of Clinical Pharmacy,Chinese
Medical Journals Publishing House,et al.Guideline for rational
medication of atrial fibrillation in primary care[J].Chin J Gen
Pract,2021,20(2):166-174.DOI:10.3760/cma.j.cn114798-20201210-01241.
[3]
Tsiachris D,Giannopoulos G,Deftereos S,et al.Biomarkers determining
prognosis of atrial fibrillation ablation[J].Curr Med
Chem,2019,26(5):925-937.DOI:10.2174/0929867325666180320122930.
[4]
Hindricks G,Potpara T,Dagres N,et al.Corrigendum to:2020 ESC Guidelines
for the diagnosis and management of atrial fibrillation developed in
collaboration with the European Association of Cardio-Thoracic Surgery
(EACTS) [J].Eur Heart
J,2021,42(5):546-547.DOI:10.1093/eurheartj/ehaa945.
[5]
中华医学会心电生理和起搏分会，中国医师协会心律学专业委员会，中国房颤中心联盟心房颤动防治专家工作委员会.心房颤动：目前的认识和治疗建议(2021)[J].中华心律失常学杂志，2022,26(1):15-88.DOI:10.3760/cma.j.cn113859-20211224-00264.Chinese
Society of Pacing and Electrophysiology,Chinese Society of
Arrhythmias,Atrial Fibrillation Center Union of China.Current knowledge
and management of atrial fibrillation:consensus of Chinese experts
2021[J].Chin J Cardiac
Arrhyth,2022,26(1):15-88.DOI:10.3760/cma.j.cn113859-20211224-00264.
[6]
Wei XM,Jiang S,Li SS,et al.Endoplasmic reticulum stress-activated
PERK-eIF2α-ATF4 signaling pathway is involved in the ameliorative
effects of ginseng polysaccharides against cisplatin-induced
nephrotoxicity in mice[J].ACS
Omega,2021,6(13):8958-8966.DOI:10.1021/acsomega.0c06339.
[7]
Jeong MH,Jeong HJ,Ahn BY,et al.PRMT1 suppresses ATF4-mediated
endoplasmic reticulum response in cardiomyocytes[J].Cell Death
Dis,2019,10(12):903.DOI:10.1038/s41419-019-2147-3.
[8]
张伯玮，张珠博，任静，等.vW因子联合D-二聚体预测非瓣膜性心房颤动患者抗凝治疗后发生血栓风险的研究[J].中华检验医学杂志，2020,43(10):1014-1020.DOI:10.3760/cma.j.cn114452-20200408-00372.Zhang
BW,Zhang ZB,Ren J,et al.von Willebrand factor and D-dimer to evaluate
the thrombosis risk in patients with nonvalvular atrial fibrillation in
anti-coagulant therapy[J].Chin J Lab
Med,2020,43(10):1014-1020.DOI:10.3760/cma.j.cn114452-20200408-00372.
[9]
中华医学会，中华医学会杂志社，中华医学会全科医学分会，等.心房颤动基层诊疗指南(2019年)[J].中华全科医师杂志，2020,19(6):465-473.DOI:10.3760/cma.j.cn114798-20191118-00838.Chinese
Medical Association,Chinese Medical Journals Publishing House,Chinese
Society of General Practice,et al.Guideline for primary care of atrial
fibrillation (2019) [J].Chin J Gen
Pract,2020,19(6):465-473.DOI:10.3760/cma.j.cn114798-20191118-00838.
[10]
Kirchhof P,Benussi S,Kotecha D,et al.2016 ESC Guidelines for the
management of atrial fibrillation developed in collaboration with
EACTS[J].Eur Heart J,2016,37(38):2893-2962.DOI:10.1093/eurheartj/ehw210.
[11]
Yang B,Jiang C,Lin Y,et al.STABLE-SR (electrophysiological substrate
ablation in the left atrium during sinus rhythm) for the treatment of
nonparoxysmal atrial fibrillation:A prospective,multicenter randomized
clinical trial[J/OL].Circ Arrhythm
Electrophysiol,2017,10(11):e005405.DOI:10.1161/CIRCEP.117.005405.
[12]
中华医学会心血管病学分会，中华心血管病杂志编辑委员会.中国左心耳封堵预防心房颤动卒中专家共识(2019)[J].中华心血管病杂志，2019,47(12):937-955.DOI:10.3760/cma.j.issn.0253-3758.2019.12.002.Chinese
Society of Cardiology of Chinese Medical Association,Editorial Board of
Chinese Journal of Cardiology.2019 Chinese Society of Cardiology (CSC)
expert consensus statement on left atrial appendage closure in the
prevention of stroke in patients with atrial fibrillation[J].Chin J
Cardiol,2019,47(12):937-955.DOI:10.3760/cma.j.issn.0253-3758.2019.12.002.
[13]
Blomstr?m-Lundqvist C,Gizurarson S,Schwieler J,et al.Effect of catheter
ablation vs antiarrhythmic medication on quality of life in patients
with atrial fibrillation:The CAPTAF Randomized Clinical
Trial[J].JAMA,2019,321(11):1059-1068.DOI:10.1001/jama.2019.0335.
[14]
Mark DB,Anstrom KJ,Sheng S,et al.Effect of catheter ablation vs medical
therapy on quality of life among patients with atrial fibrillation:The
CABANA randomized clinical
trial[J].JAMA,2019,321(13):1275-1285.DOI:10.1001/jama.2019.0692.
[15]
Packer DL,Mark DB,Robb RA,et al.Effect of catheter ablation vs
antiarrhythmic drug therapy on mortality,stroke,bleeding,and cardiac
arrest among patients with atrial fibrillation:The CABANA randomized
clinical
trial[J].JAMA,2019,321(13):1261-1274.DOI:10.1001/jama.2019.0693.
[16]
杨丽红，王庆义，李涵，等.自主神经功能障碍对阵发性房颤射频导管消融术后复发影响的直立倾斜试验预测分析[J].中国实用神经疾病杂志，2021,24(3):214-219.DOI:10.12083/SYSJ.2021.03.016.Yang
LH,Wang QY,Li H,et al.HUTT predictive analysis of the influence of
autonomic dysfunction on the recurrence of paroxysmal atrial
fibrillation after radiofrequency catheter ablation[J].Chinese Journal
of Practical Neurological
Diseases,2021,24(3):214-219.DOI:10.12083/SYSJ.2021.03.016.
[17]
Chen YC,Voskoboinik A,Gerche A,et al.Prevention of pathological atrial
remodeling and atrial fibrillation:JACC State-of-the-Art Review[J].J Am
Coll Cardiol,2021,77(22):2846-2864.DOI:10.1016/j.jacc.2021.04.012.
[18]
Kaspar S,Oertlin C,Szczepanowska K,et al.Adaptation to mitochondrial
stress requires CHOP-directed tuning of ISR[J].Sci
Adv,2021,7(22):eabf0971.DOI:10.1126/sciadv.abf0971.
[19]
Zhang Y,Yang S,Fu J,et al.Inhibition of endoplasmic reticulum stress
prevents high-fat diet mediated atrial fibrosis and fibrillation[J].J
Cell Mol Med,2020,24(23):13660-13668.DOI:10.1111/jcmm.15816.
[20]
Harding HP,Zhang Y,Zeng H,et al.An integrated stress response regulates
amino acid metabolism and resistance to oxidative stress[J].Mol
Cell,2003,11(3):619-633.DOI:10.1016/s1097-2765(03)00105-9.
[21]
Freundt JK,Frommeyer G,Wotzel F,et al.The transcription factor ATF4
promotes expression of cell stress genes and cardiomyocyte death in a
cellular model of atrial fibrillation[J].Biomed Res
Int,2018,2018:3694362.DOI:10.1155/2018/3694362.
[22]
Corban MT,Toya T,Ahmad A,et al.Atrial fibrillation and endothelial
dysfunction:A Potential Link[J].Mayo Clin
Proc,2021,96(6):1609-1621.DOI:10.1016/j.mayocp.2020.11.005.
[23]
Zeineddin A,Dong JF,Wu F,et al.Role of von willebrand factor after
injury:It may do more than we
think[J].Shock,2021,55(6):717-722.DOI:10.1097/SHK.0000000000001690.
[24]
贾静，付微，唐山丹，等.心房颤动射频消融术后血栓栓塞事件的危险因素研究[J].中华保健医学杂志，2021,23(6):580-582.DOI:10.3969/j.issn.1674-3245.2021.06.006.Jia
J,Fu W,Tang SD,et al.Risk factors of thromboembolism after
radiofrequency ablation of atrial fibrillation[J].Chin J Health Care
Med,2021,23(6):580-582.DOI:10.3969/j.issn.1674-3245.2021.06.006.
[25]
Zhong C,Xin M,He L,et al.Prognostic value of von Willebrand factor in
patients with atrial fibrillation:A meta-analysis[J].Medicine
(Baltimore),2018,97(27):e11269.DOI:10.1097/MD.0000000000011269.
[26]
Ding WY,Gupta D,Lip GYH.Atrial fibrillation and the prothrombotic
state:revisiting Virchow's triad in
2020[J].Heart,2020,106(19):1463-1468.DOI:10.1136/heartjnl-2020-316977.
